Article
Combining computational modeling and experimental library screening to affinity-mature VEEV-neutralizing antibody F5
2024-07-09
Abstract excerpt
<h4>ABSTRACT</h4> Engineered monoclonal antibodies (mAbs) have proven to be highly effective therapeutics in recent viral outbreaks due to their specificity and ability to provide immediate protection, regardless of immune status. However, despite technical advancements in the field, an ability to rapidly adapt or increase antibody affinity and by extension, therapeutic efficacy, has yet to be fully realized. We...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7be8a5fd-c08a-5246-b463-6212c696d4cc
- DOI
- 10.1101/2024.07.08.602599
